Publisher: Cambridge University Press
E-ISSN: 1601-5215|26|6|327-333
ISSN: 0924-2708
Source: Acta Neuropsychiatrica, Vol.26, Iss.6, 2013-06, pp. : 327-333
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Personalised medicine has finally been featured in psychiatric journals, but psychiatrists have mainly focused on the promise of using disease mechanisms to personalise treatment. Psychiatric disorders such as schizophrenia and depression are not diseases, in the medical sense, and are probably more like syndromes. Instead of spending much time and effort focusing on the mechanisms of diseases that may instead be syndromes, the author believes that psychiatrists should (1) learn more about personalising prescription via drug mechanisms, a pharmacological approach to personalised medicine; and (2) reconsider prior attempts by traditional clinical psychopharmacologists to use sophisticated clinical approaches that try to subdivide psychiatric syndromes into groups that may be more homogenous for treatment response.
Related content
Personalised medicine in psychiatry? Yes, but how?
Acta Neuropsychiatrica, Vol. 26, Iss. 6, 2014-11 ,pp. :
History of the Introduction of Lithium into Medicine and Psychiatry
Acta Neuropsychiatrica, Vol. 22, Iss. 3, 2010-06 ,pp. :
Standard electroencephalography in clinical psychiatry: a practical handbook
Acta Neuropsychiatrica, Vol. 23, Iss. 5, 2011-10 ,pp. :
Routine clinical outcomes measurement in old age psychiatry
International Psychogeriatrics, Vol. 21, Iss. 6, 2009-12 ,pp. :